Insider Selling: Chemed (NYSE:CHE) CEO Sells $1,082,320.00 in Stock

Chemed Corporation (NYSE:CHE) CEO Kevin Mcnamara sold 2,000 shares of the firm’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $541.16, for a total value of $1,082,320.00. Following the completion of the sale, the chief executive officer owned 70,418 shares of the company’s stock, valued at $38,107,404.88. This represents a 2.76% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link.

Chemed Stock Performance

CHE opened at $548.27 on Thursday. The stock has a market cap of $7.17 billion, a PE ratio of 27.54, a P/E/G ratio of 2.06 and a beta of 0.51. The company has a current ratio of 0.91, a quick ratio of 0.89 and a debt-to-equity ratio of 0.17. Chemed Corporation has a 1 year low of $365.20 and a 1 year high of $557.00. The stock’s 50 day simple moving average is $506.04 and its 200-day simple moving average is $448.64.

Chemed (NYSE:CHE) last issued its earnings results on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The business had revenue of $673.25 million during the quarter, compared to analyst estimates of $665.04 million. During the same period in the prior year, the company posted $4.27 earnings per share. Chemed’s revenue was up 8.8% on a year-over-year basis. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Sell-side analysts forecast that Chemed Corporation will post 23.18 EPS for the current year.

Chemed Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Monday, August 17th will be issued a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend is Monday, August 17th. This is a positive change from Chemed’s previous quarterly dividend of $0.60. Chemed’s payout ratio is 14.06%.

Analyst Ratings Changes

CHE has been the topic of several recent research reports. Bank of America reiterated a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. Weiss Ratings upgraded shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. Oppenheimer lifted their price objective on Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a report on Friday, July 31st. Royal Bank Of Canada lifted their price objective on Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a report on Thursday, July 30th. Finally, Wall Street Zen upgraded Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday, August 1st. One analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $530.75.

Institutional Investors Weigh In On Chemed

Several institutional investors and hedge funds have recently made changes to their positions in the company. California State Teachers Retirement System increased its holdings in shares of Chemed by 45,134.8% during the second quarter. California State Teachers Retirement System now owns 7,613,918 shares of the company’s stock worth $3,546,106,000 after buying an additional 7,597,086 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its stake in shares of Chemed by 2,444,879.3% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company’s stock valued at $2,374,667,000 after acquiring an additional 5,549,876 shares during the last quarter. BlackRock Inc. acquired a new position in shares of Chemed in the 2nd quarter worth approximately $691,290,000. Norges Bank acquired a new position in shares of Chemed in the 4th quarter worth approximately $76,067,000. Finally, AQR Capital Management LLC grew its position in Chemed by 89.2% during the 4th quarter. AQR Capital Management LLC now owns 325,579 shares of the company’s stock worth $139,302,000 after acquiring an additional 153,469 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.